<?xml version="1.0" encoding="UTF-8"?>
<ref id="pmed.1002882.ref071">
 <label>71</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Brooks</surname>
   <given-names>KM</given-names>
  </name>, 
  <name>
   <surname>George</surname>
   <given-names>JM</given-names>
  </name>, 
  <name>
   <surname>Pau</surname>
   <given-names>AK</given-names>
  </name>, 
  <name>
   <surname>Rupert</surname>
   <given-names>A</given-names>
  </name>, 
  <name>
   <surname>Mehaffy</surname>
   <given-names>C</given-names>
  </name>, 
  <name>
   <surname>De</surname>
   <given-names>P</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Cytokine-Mediated Systemic Adverse Drug Reactions in a Drug-Drug Interaction Study of Dolutegravir With Once-Weekly Isoniazid and Rifapentine</article-title>. 
  <source>Clin Infect Dis</source>. 
  <year>2018</year>;
  <volume>67</volume>(
  <issue>2</issue>):
  <fpage>193</fpage>â€“
  <lpage>201</lpage>. Epub 2018/02/08. 
  <pub-id pub-id-type="doi">10.1093/cid/ciy082</pub-id>
  <?supplied-pmid 29415190?>
  <pub-id pub-id-type="pmid">29415190</pub-id>
 </mixed-citation>
</ref>
